Detectable Concentrations With Inhaled Tobramycin in Critically Ill Infants and Children Following Implementation of Standardized Protocol
Annals of Pharmacotherapy · 2025
DOI: 10.1177/10600280241282433 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Annals of Pharmacotherapy, 2025. Verfasst von Peter N Johnson und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Clinical and Administrative Sciences, College of Pharmacy, The University of Oklahoma, Oklahoma City, OK, USA. Hauptthemen laut MEDLINE: Tobramycin, Anti-Bacterial Agents. Die Arbeit nennt 23 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
A protocol was established for ventilator-associated tracheitis or pneumonia using inhaled tobramycin 300 mg every 12 hours in mechanically ventilated children via a vibrating mesh nebulizer, 30 cm from the endotracheal tube in the inspiratory loop of the mechanical ventilator.
Objectives
The primary objective was to determine the incidence of detectable tobramycin trough concentrations >0.5 µg/mL. Secondary objectives included a comparison of clinical characteristics between those with and without detectable concentrations and identification of patients with acute kidney injury (AKI) as defined by the Kidney Diseases Improving Global Outcomes (KDIGO) criteria.
Methods
This was a single-center retrospective study of critically ill children
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Clinical and Administrative Sciences, College of Pharmacy, The University of Oklahoma, Oklahoma City, OK, USA.
- Department of Pharmacy, Bethany Children's Health Center, Bethany, OK, USA.
- Department of Pharmacy, Banner-University Health Center Tucson, Tucson, AZ, USA.
- Department of Pharmacy, INTEGRIS Baptist Medical Center, Oklahoma City, OK, USA.
- Office of Instruction, Assessment, & Faculty/Staff Development, College of Pharmacy, The University of Oklahoma, Oklahoma City, OK, USA.
- Department of Pediatrics, Section of Critical Care, College of Medicine, The University of Oklahoma, Oklahoma City, OK, USA.
ORCID-Profile: Peter N Johnson, Jamie L Miller
Zitieren
APA
Johnson, P. N., Chang, E., Cormack, E., Hornaday, K., Neely, S. B., Ranallo, C., Chaaban, H., Garcia-Contreras, L., & Miller, J. L. (2025). Detectable Concentrations With Inhaled Tobramycin in Critically Ill Infants and Children Following Implementation of Standardized Protocol. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280241282433
Vancouver
Johnson PN, Chang E, Cormack E, Hornaday K, Neely SB, Ranallo C, et al. Detectable Concentrations With Inhaled Tobramycin in Critically Ill Infants and Children Following Implementation of Standardized Protocol. Annals of Pharmacotherapy. 2025. doi:10.1177/10600280241282433
BibTeX
@article{Johnson2025,
author = {Johnson, Peter N and Chang, Eugenie and Cormack, Emily and Hornaday, Kaley and Neely, Stephen B and Ranallo, Courtney and Chaaban, Hala and Garcia-Contreras, Lucila and Miller, Jamie L},
title = {Detectable Concentrations With Inhaled Tobramycin in Critically Ill Infants and Children Following Implementation of Standardized Protocol},
journal = {Annals of Pharmacotherapy},
year = {2025},
doi = {10.1177/10600280241282433}
}
EUVIMED